Search - tctmd.com

Displaying 1 - 20 of 252

Sort: Relevancy | Date

Presentation Cardiovascular Interventions 2025

Cardiology’s Evidence Crisis and What We Can Do About It

Presenter: Robert W. Yeh

November 14, 2025

Presentation TCT 2025

VITALYST™

Presenter: Robert W. Yeh

October 27, 2025

Presentation TCT 2025

Hybrid Trial Designs and Real-World Evidence: Will They Ever Be Prime Time?

Presenter: Robert W. Yeh

October 27, 2025

Presentation TCT 2025

Closing Thoughts

Presenter: Robert W. Yeh

October 26, 2025

Presentation TCT 2025

Case Discussion

Presenter: Robert W. Yeh

October 26, 2025

Presentation TCT 2025

Panel Discussion: Why Does the MOA of Bioadaptor Matter? Impact on Patients Outcomes in PCI

Presenter: Robert W. Yeh

October 26, 2025

Presentation CTO 2025

Overview of the FORWARD CAD IDE Study

Presenter: Robert Yeh

February 28, 2025

Presentation THT 2025

Harnessing Real World Data to Test Emerging Technologies

Presenter: Robert Yeh

February 11, 2025

Presentation Cardiovascular Interventions 2024

Difficult Stent Delivery: Tips and Tricks

Presenter: Robert W. Yeh

November 11, 2024

Presentation TCT 2024

Balancing Clinical Outcomes with Utilization in Clinical Practice - Case Example = The Agent ISR DCB

Presenter: Robert Yeh

October 29, 2024

Presentation TCT 2024

How Far Can We Push Observational Data to Answer Clinical Questions: Statistical Considerations

Presenter: Robert Yeh

October 28, 2024

News Daily News

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Michael O'Riordan

July 01, 2024

Podcast TCTMD Talking Points

The AGENT IDE Trial

June 05, 2024

News Conference News EuroPCR 2024

ORBITA-2: Angina Phenotype Strongly Predicts PCI Response

Caitlin E. Cox

May 15, 2024

News Features

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Caitlin E. Cox

May 02, 2024

News Conference News CRT 2024

Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis

L.A. McKeown

March 09, 2024

News Daily News

Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis

L.A. McKeown

March 01, 2024

Presentation CTO 2024

Should ORBITA2 Change How I Think About CTO PCI?

Presenter: Robert W. Yeh

February 02, 2024

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

Advertisement

Cardiology’s Evidence Crisis and What We Can Do About It

VITALYST™

Hybrid Trial Designs and Real-World Evidence: Will They Ever Be Prime Time?

Closing Thoughts

Case Discussion

Panel Discussion: Why Does the MOA of Bioadaptor Matter? Impact on Patients Outcomes in PCI

Overview of the FORWARD CAD IDE Study

Harnessing Real World Data to Test Emerging Technologies

Difficult Stent Delivery: Tips and Tricks

Balancing Clinical Outcomes with Utilization in Clinical Practice - Case Example = The Agent ISR DCB

How Far Can We Push Observational Data to Answer Clinical Questions: Statistical Considerations

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

The AGENT IDE Trial

ORBITA-2: Angina Phenotype Strongly Predicts PCI Response

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis

Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis

Should ORBITA2 Change How I Think About CTO PCI?

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content